HIGHLIGHTS
- who: from the (UNIVERSITY) have published the article: Rare lung diseases II: Pulmonary alveolar proteinosis, in the Journal: (JOURNAL)
- what: Like lymphangioleiomyomatosis, PAP is a disease in which significant conceptual and therapeutic advances have been made as a result of investigations into the fundamental biological aberrations that characterize the disorder.
- how: There may be a mild associated lymphocytic infiltrate in the interstitium but this feature is minor in comparison with the findings in the alveolar compartment.
SUMMARY
The discussion of PAP will begin with a case report, then will . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.